Antiviral. Who can be treated with them and who can’t?

Recent, Ministry of Health provided a series of information related to anti-COVID treatments used in Romania. They have strict recommendations, depending on the symptoms and other possible factors.

These drugs, oral antivirals used in Romania, can be administered only with the consent of specialists, according to procedures and recommendations.

Who is recommended oral antivirals for?


“It is used in the treatment of SARS-CoV-2 virus infection in adults with mild to moderate forms of COVID-19. Favipiravir reduces the duration of viral excretion in the respiratory tract, as well as the duration and intensity of symptoms in COVID-19, without reducing mortality and hospitalization in ICU departments “, transmits the Ministry of Health.

You may also be interested in: Major differences between vaccinated and unvaccinated. C …

According to the quoted source, “Favipiravir is contraindicated for pregnant women or those suspected of being pregnant. Women of childbearing potential should use very effective methods of contraception during treatment and for at least 7 days after stopping treatment. If patients suspect that they are pregnant, a pregnancy test will be performed to rule out the possibility of pregnancy before starting treatment. If pregnancy occurs, patients should discontinue favipiravir and consult a physician immediately.

Favipiravir should not be used in women who are breast-feeding unless they wish to stop breast-feeding. Also, sexually active men should use condoms during treatment and for at least 7 days after stopping treatment. “

You may also be interested in: Sick kidney symptoms. Alarm signs showing …

Patients should be alert to signs or symptoms that may suggest drug-induced liver damage: fatigue, loss of appetite, abdominal discomfort in the right side of the abdomen, dark urine, or jaundice. The use of favipiravir should be discontinued if these symptoms occur, the ministry said.


“It is a combination of medicines (including Nirmatrelvir and Ritonavir) authorized by the EMA (European Medicines Agency) only for the treatment of mild to moderate forms of COVID-19 in adults who are at increased risk of developing severe disease and death. , and which does not require additional oxygen.

You may also be interested in: Anti-COVID treatments used in Romania. Who …

Paxlovid is NOT authorized for:

– treatment of patients requiring hospitalization with a severe or critical form of COVID19;

– prevention of COVID-19 when you come in close contact with a person diagnosed with COVID-19;

– use for more than five consecutive days “, it is also shown in the communiqué.

Paxlovid can only be used after a prior clinical and laboratory evaluation of the patient, and can be released both in the hospital for the hospitalized patient and in the outpatient setting by the COVID-19 Evaluation Center.

You may also be interested in: New restrictions in Bucharest, after entering the scene …


“Molnupiravir (Lagrevio) is approved for the treatment of mild to moderate forms of COVID-19 in adults at high risk of progression to severe disease and death.

Molnupiravir is NOT authorized for:

– use in patients under 18 years of age.

– treatment of patients requiring hospitalization due to COVID-19, as the benefit of Molnupiravir treatment has not been seen in patients with severe COVID19.

You may also be interested in: The reason why doctors recommend water from ro …

– use for more than five consecutive days.

– prevention of COVID-19 in people who have come in contact with a patient diagnosed with COVID-19 “, also shows MS.

What happens to Arbidol and ivermectin

“Umifenovir (Arbidol) is an active influenza antiviral used in Russia and China, the effectiveness of which in COVID-19 has NOT been demonstrated by scientific studies. Umifenovir is not authorized in the European Union or by the Romanian National Medicines Agency. Therefore, it cannot be sold in pharmacies. In our country it was used sporadically and was purchased from the former Soviet Union.

Please note that in addition to the lack of efficacy data in COVID-19, the unofficial procurement of this medicine and its over-the-counter use involves risks related to the mode of manufacture, storage and transport. TREATMENTS WITH IVERMECTIN, LOPINAVIR / RITONAVIR (KALETRA), HYDROXYCHLOROCHINE, AZITHROMYCIN ARE NOT EFFECTIVE IN COVID-19 AND SHOULD NOT BE USED. USING THEM CAN ENDANGER YOUR LIFE! ”, Concludes the communiqué of the Ministry of Health.

The information presented on this website is informative and does not replace the medical diagnosis or product leaflet. Any decision about your health should only be made after consultation with your doctor.

Source: DoctorulZilei by

*The article has been translated based on the content of DoctorulZilei by If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!